classical Hodgkin lymphoma
Conditions
Interventions
None listed
Sponsors
Pathologie en Medische Biologie
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Age > 18 years Ability to give written informed consent HLA type known
Exclusion criteria
Exclusion criteria: active infectious, autoimmune or malignant disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disentangling mechanisms of interaction between lymphocytes and Hodgkin tumor cell lines in vitro. | — |
Secondary
| Measure | Time frame |
|---|---|
| geen | — |
Countries
Netherlands
Outcome results
None listed